ACCEL Absorbable Hemostat

NARecruitingINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

October 26, 2021

Primary Completion Date

November 30, 2024

Study Completion Date

January 30, 2025

Conditions
Hemostasis
Interventions
DEVICE

ACCEL® Absorbable Hemostat Powder

Up to 2 bellows (10 grams nominal) of ACCEL®

DEVICE

Gelfoam® (Absorbable Gelatin Sponge, Pfizer Manufacturer Part Number 0342-01)

Up to 12.5 cm x 8.0 cm of Gelfoam® or SURGIFOAM® .

Trial Locations (7)

53792

RECRUITING

University of Wisconsin - Madison, Madison

63110

RECRUITING

Washington University in St. Louis, St Louis

RECRUITING

Washington University in St. Louis, St Louis

64111

COMPLETED

Saint Luke's Hospital of Kansas City, Kansas City

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

RECRUITING

University of Texas Southwestern Medical Center, Dallas

90033

COMPLETED

Keck Medical Center of USC, Los Angeles

All Listed Sponsors
lead

Hemostasis, LLC

INDUSTRY